More than 60 attendees including alumni, medtech leaders and innovators, friends and family converged at Fogarty Innovation to celebrate the Ferolyn Fellowship’s (FF) class of 2022 – 2023: Amy Degenkolb, co-founder and CEO, Novocuff, Bev Tang, co-founder and CEO...
For the past decade, Fogarty Innovation has hosted the Lefteroff summer internship, drawing a group each year of enterprising young men and women eager to delve into the dynamic field of medical innovation and related careers. The program...
Boomerang Medical, a women-led bioelectronic medicine company, is on the verge of completing enrollment in the second stage of its FDA-approved pilot trial studying neuromodulation as a therapeutic approach for Inflammatory Bowel Disease (IBD). The company is on a...
For 25 years, the annual Thomas J. Fogarty Lecture series has inspired us to engage with the healthcare visionaries who have taken the stage to share stories of inventions and leadership that have transformed patient care. In a special 25th anniversary lecture...
Key factors that drive success for startups include a brilliant innovation, creative engineering, a strong leadership team and a sound regulatory strategy. What can often be overlooked until it’s too late is that without a path to reimbursement, a device is unlikely...
Early-stage medtech companies apply to Fogarty Innovation’s incubation and acceleration programs for many reasons, from its state-of-the-art facilities to its proximity to El Camino Hospital. But the biggest draw by far is the intensive, hands-on coaching provided by...
Building on the success of last year's inaugural event, FI and CRF expand the scope of their market-focused MedTech Innovation Forum
Building on the success of last year’s standing-room-only debut, Fogarty Innovation and the Cardiovascular Research Foundation (CRF) are teaming up again to host an even more dynamic MedTech Innovation Forum at TCT (Transcatheter Cardiovascular Therapeutics) this...
An in-depth look at Fogarty Innovation's alliance and education programs
How Andrew Cleeland is building on Tom Fogarty's legacy to take Fogarty Innovation forward. Part 1 of 2